P1192: ANTI-PD-1 ANTIBODY (TISLELIZUMAB) COMBINED WITH R-CHOP FOR THE TREATMENT OF PREVIOUSLY UNTREATED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PROSPENTIVE PHASE II STUDY

Bibliographic Details
Title: P1192: ANTI-PD-1 ANTIBODY (TISLELIZUMAB) COMBINED WITH R-CHOP FOR THE TREATMENT OF PREVIOUSLY UNTREATED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PROSPENTIVE PHASE II STUDY
Authors: Wu Mei, Zhu Lin, LI Shan, Tu Erde Jia Erbao, Wang Shanshan, Liang Xiao, Hu Xin, Guo LI, A Dili Abulikemujiang, Maimaitirexiati Xianmusiya, Ren Ruirui, Wen Shujuan
Source: HemaSphere, Vol 7, p e0862074 (2023)
Publisher Information: Wiley, 2023.
Publication Year: 2023
Collection: LCC:Diseases of the blood and blood-forming organs
Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2572-9241
Relation: http://journals.lww.com/10.1097/01.HS9.0000971664.08620.74; https://doaj.org/toc/2572-9241
DOI: 10.1097/01.HS9.0000971664.08620.74
Access URL: https://doaj.org/article/04f07fe38fc749e49f9d042cb8f641d4
Accession Number: edsdoj.04f07fe38fc749e49f9d042cb8f641d4
Database: Directory of Open Access Journals
More Details
ISSN:25729241
DOI:10.1097/01.HS9.0000971664.08620.74
Published in:HemaSphere
Language:English